Drug Shortage Report for LEVETIRACETAM
Report ID | 63410 |
Drug Identification Number | 02474468 |
Brand name | LEVETIRACETAM |
Common or Proper name | Levetiracetam |
Company Name | LABORATOIRE RIVA INC. |
Market Status | CANCELLED PRE MARKET |
Active Ingredient(s) | LEVETIRACETAM |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 120 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-10-05 |
Actual start date | 2018-10-05 |
Estimated end date | Unknown |
Actual end date | 2019-10-24 |
Shortage status | Resolved |
Updated date | 2019-11-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-11-06 | French | Compare |
v4 | 2019-11-06 | English | Compare |
v3 | 2018-10-06 | English | Compare |
v2 | 2018-10-05 | French | Compare |
v1 | 2018-10-05 | English | Compare |
Showing 1 to 5 of 5